Inventor · disambiguated record
Csaba Kari
Also filed as: KARI CSABA
7 granted patents·4 pending applications·71 citations·filing 1979–2022
84Inventor score
Top patents by PatentIndex Score
11 records- 0196US10357571B2Development of masked therapeutic antibodies to limit off-target effectsHOPE CITY·Filed 2015·Granted Jul 23, 2019·18 cites·8 claims
- 0294US8895702B2Development of masked therapeutic antibodies to limit off-target effects; application to anti-EGFR antibodiesWILLIAMS JOHN C·Filed 2012·Granted Nov 25, 2014·27 cites·4 claims
- 0381US11311622B2Development of masked therapeutic antibodies to limit off-target effectsHOPE CITY·Filed 2019·Granted Apr 26, 2022·1 cites·5 claims
- 0476US2023085485A1Design and development of masked therapeutic antibodies to limit off-target effectsHOPE CITY·Filed 2022·Application pending·0 cites
- 0562US2016152711A1Design and development of masked therapeutic antibodies to limit off-target effects: application to anti-egfr antibodiesHOPE CITY·Filed 2014·Application pending·0 cites
- 0660US11186642B2Development of masked therapeutic antibodies to limit off-target effects: application to anti-EGFR antibodiesHOPE CITY·Filed 2017·Granted Nov 30, 2021·0 cites·9 claims
- 0757US6448389B1Human cytomegalovirus DNA constructs and uses thereforWISTAR INST·Filed 1997·Granted Sep 10, 2002·19 cites·3 claims
- 0851US2003120060A1Human cytomegalovirus DNA constructs and uses thereforFiled 2002·Application pending·0 cites
- 0937US2011178279A1Development of masked therapeutic antibodies to limit off-target effects: application to anti-egfr antibodiesWILLIAMS JOHN C·Filed 2010·Application pending·0 cites
- 1030US5183748AProcess for the preparation of oligo- and polydeoxyribonucleotidesVEPEX CONTRACTOR LTD·Filed 1985·Granted Feb 2, 1993·5 cites·10 claims
- 1121US4294927AGenetic process for the preparation of antibiotic-producer micromonospora strainsGYOGYSZERKUTATO INTEZET·Filed 1979·Granted Oct 13, 1981·1 cites·9 claims
Join the waitlist — get patent alerts
Get an alert when Csaba Kari files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →